SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 5.5 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS

被引：0
|
作者：
Genovese, M. C. [1 ]
Smolen, J. S. [2 ]
Takeuchi, T. [3 ]
Hyslop, D. [4 ]
Macias, W. L. [4 ]
Rooney, T. P. [4 ]
Chen, L. [4 ]
Dickson, C. L. [4 ]
Camp, J. R. [4 ]
Cardillo, T. E. [4 ]
Ishii, T. [5 ]
Winthrop, K. L. [6 ]
Garcia, E. G. [4 ]
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Med Univ Vienna, Vienna, Austria
[3] Keio Univ, Tokyo, Japan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Kobe, Hyogo, Japan
[6] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
375
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 5.5 Years: An Updated Integrated Safety Analysis
    Genovese, Mark C.
    Smolen, Josef S.
    Takeuchi, Tsutomu
    Hyslop, David
    Macias, William L.
    Rooney, Terence P.
    Chen, Lei
    Dickson, Christina L.
    Camp, Jennifer Riddle
    Cardillo, Tracy
    Ishii, Taeko
    Winthrop, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis
    Genovese, M.
    Smolen, J.
    Takeuchi, T.
    Hyslop, D.
    Macias, W.
    Rooney, T.
    Chen, L.
    Dickson, C.
    Riddle, J.
    Cardillo, T.
    Ishii, T.
    Winthrop, K.
    Larsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 35 - 35
  • [3] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 5.5 Years: An Updated Integrated Safety Analysis
    Keystone, Edward
    Genovese, Mark
    Smolen, Josef
    Takeuchi, Tsutomu
    Hyslop, David
    Macias, William
    Rooney, Terence
    Chen, Lei
    Dickson, Christina
    Camp, Jennifer
    Cardillo, Tracy
    Ishii, Taeko
    Winthrop, Kevin
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1003 - 1003
  • [4] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Genovese, M.
    Smolen, J.
    Takeuchi, T.
    Gerd, B.
    Brinker, D.
    Rooney, T.
    Zhong, J.
    Mo, D.
    Saifan, C.
    Cardoso, A.
    Issas, M.
    Wu, W.
    Winthrop, K.
    Gomez-Martin, D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 133 - 133
  • [5] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 6 Years: An Updated Integrated Safety Analysis
    Genovese, Mark C.
    Smolen, Josef S.
    Takeuchi, Tsutomu
    Rooney, Terence P.
    Dickson, Christina L.
    Yang, Xiao-Yan
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Ishii, Taeko
    Winthrop, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 9.3 Years: An Updated Integrated Safety Analysis
    Taylor, Peter C.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Durez, Patrick
    Smolen, Josef
    Deberdt, Walter
    Zhong, Jinglin
    Terres, Jorge Ross
    Bello, Natalia
    Winthrop, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3516 - 3518
  • [7] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 7 Years: An Updated Integrated Safety Analysis
    Genovese, Mark
    Smolen, Josef
    Takeuchi, Tsutomu
    Burmester, Gerd
    Brinker, Dennis
    Rooney, Terence
    Zhong, Jinglin
    Mo, Daojun
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Wu, Wen-Shuo
    Winthrop, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Bird, Paul
    Winthrop, Kevin
    Takeuchi, Tsutomu
    Burmester, Gerd
    Durez, Patrick
    Deberdt, Walter
    Schlichting, Doug
    Beattie, Scott
    Mo, Daojun
    Walls, Chad
    Smolen, Josef
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 24 - 24
  • [9] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Genovese, M. C.
    Smolen, J. S.
    Takeuchi, T.
    Burmester, G. R.
    Deberdt, W.
    Schlichting, D.
    Song, H.
    Mo, D.
    Walls, C.
    Winthrop, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 638 - 639
  • [10] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 9.3 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Taylor, Peter C.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Durez, Patrick
    Smolen, Josef
    Deberdt, Walter
    Zhong, Jinglin
    Terres, Jorge Ross
    Bello, Natalia
    Winthrop, Kevin
    RHEUMATOLOGY, 2022, 61
12345